• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Moldova Pharmaceuticals and Healthcare Report Q2 2009 - Product Image

Moldova Pharmaceuticals and Healthcare Report Q2 2009

  • ID: 940939
  • April 2009
  • Region: Moldova
  • 54 Pages
  • Business Monitor International

Moldova Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Moldova's pharmaceuticals and healthcare industry.

Moldova’s pharmaceutical market stood at US$206mn in 2008 and is forecast to grow to US$309mn in 2013. This represents a compound annual growth rate (CAGR) of 14.08%. The country has seen its healthcare budget almost triple since the introduction of obligatory health insurance in 2003, and in the coming years, growth in the drug market will be driven by the continuing modernization of the health sector. In 2009, for example, the health insurance budget increased by 30% compared to 2008. In February 2009, three legislative amendments were adopted by Molodova’s parliament, giving low income families the right to free health insurance. Families that already receive social assistance will be given full insurance coverage, as part of the government’s 2008-2017 plan to increase access to health services.

Presently, there are 17 categories of people who receive free health insurance, this includes – children, retirees, the disabled, students, pregnant women and the unemployed. It is estimated by READ MORE >

Note: Product cover images may vary from those shown

Executive Summary

SWOT Analysis.

Moldova Pharmaceuticals And Healthcare Industry SWOT

Pharmaceutical Business Environment Ratings

Table: Pharmaceutical Business Environment Ratings

Limits To Potential Returns

Risks To Realisation Of Returns

Moldova - Market Summary

Regulatory Regime.

Intellectual Property Rights

Pricing Regime

Reimbursement Regime

Table: Republic of Moldova - Out-of-pocket Payments for Healthcare

International Trade Agreements

Industry Developments

Epidemiology.

Table: Republic of Moldova - Top 10 Causes of Death .

Table: Republic of Moldova – Leading Causes Of Morbidity As % of Total Disease Burden

Republic of Moldova - Acute Tuberculosis Morbidity ('000 population)

Healthcare Sector

Table: Republic of Moldova - Voluntary Health Insurance Indicators

Primary Care.

Secondary Care

Compulsory Health Insurance

Table: Republic of Moldova – Social Health Insurance (SHI) Contributions By Source (As % Of Total) .

Table: Republic of Moldova – The Flat-Rate Contributions for Self-Insured/Per Capita Budget Contributions For The Unemployed.

Pharmaceutical Industry

Pharmaceutical Wholesale

Pharmaceutical Retail

Research and Development

Medical Devices.

Industry Forecast Scenario

Overall Market Forecast

Table: Moldova – Drug Market Expenditure, 2003-2013 (MDLmn unless otherwise stated)

Key Growth Factors – Industry

Table: Moldova – Health Expenditure, 2003-2013 (MDLmn unless otherwise stated)

Prescription Drug Market Forecast.

Table: Moldova - Prescription Drug Market, 2003-2013 (MDLmn unless otherwise stated)

Patented Drug Market Forecast

Table: Moldova - Patented Drug Market, 2003-2013

Generic Drug Market Forecast

Table: Moldova – Generic Drug Market, 2003-2013.

OTC Drug Market Forecast.

Table: Moldova – OTC Market, 2003-2013 (MDLmn unless otherwise stated).

Pharmaceutical Export/Import Forecast

Table: Moldova – Pharmaceutical Trade Balance, 2003-2013 (US$mn)

Other Healthcare Data Forecasts

Table: Moldova – Other Health Indicators, 2003-2013.

Key Risks To BMI’s Forecasts

Competitive Landscape

Table: Republic Of Moldova – Top 10 Local Manufacturers (H107)

Table: Republic Of Moldova – Top 10 Manufacturers By Value

Table: Republic of Moldova – Top 10 Trade, INNs/Combinations And ATC Groups As Percentages Of Total Market Value (H108)

Company Profiles.

Foreign Companies

Gedeon Richter

Indigenous Companies.

Farmaco

Top Pharm.

BMI Forecast Modelling.

How We Generate Our Pharmaceutical Industry Forecasts

Pharmaceutical Business Environment Ratings Methodology .

Ratings Overview.

Table: Pharmaceutical Business Environment Indicators .

Weighting.

Table: Weighting Of Components

Sources

Note: Product cover images may vary from those shown

- Gedeon Richter

- Farmaco

- Top Pharm

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

ALSO AVAILABLE

RELATED PRODUCTS

Our Clients

Our clients' logos